Physicians' Health Study I
Initiatives
-
To test the benefits and risks of aspirin and beta carotene in the primary prevention of cardiovascular disease and cancer.
**General contact: phs@rics.bwh.harvard.edu
**
- Start Year
- 1980
- End Year
- 1995
- Funding
- The Physicians' Health Study-I was supported by four grants from the National Institutes of Health: CA-34944 and CA-40360 from the National Cancer Institute, and HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute.
Visit PHS-I
Investigators | Contacts |
---|---|
|
Design
- Study design
- Clinical trial cohort
- Follow Up
- The first follow-up questionnaires were sent at six and 12 months of treatment. After that, questionnaires were sent yearly. They included questions about compliance with the study treatments, use of non-study medications, occurrence of major illnesses or adverse effects, and other risk factor information.
Marker Paper
Steering Committee of the Physicians' Health Study Research Group. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1988 Jan 28;318(4):262-4. doi: 10.1056/NEJM198801283180431.
PUBMED 3275899
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 22,071
- Number of participants with biosamples
- Supplementary Information
- Male physicians between 40 and 84 years of age who lived in the United States and who were registered with the American Medical Association.
Access
Availability of data and biosamples
Data | |
Biosamples | |
Other |